Skip to content
Home/Companies/Pharma/Mirum Pharmaceuticals

Mirum Pharmaceuticals

Pharma·US·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals is currently owned by Novo Holdings through Novo Holdings Growth Investments (1999 vintage), since 2018.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQUnited States
SectorPharma
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
AvenCell
Active
BiotechUS· 2024
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Mirum Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Mirum Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Mirum Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue